Imalumab

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameImalumab
Drug Alias NameBAX-69BAX-069
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionMacrophage migration inhibitory factor inhibitorsImmunomodulators
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsOvarian NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytokine Pharmasciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaxalta Incorporated
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia